Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of this exploratory trial is to evaluate the comparative safety through week 12 of two treatment transition strategies in patients with inadequate response to methotrexate: discontinuation of methotrexate with immediate initiation of ustekinumab versus initiation of ustekinumab with overlap and gradual dose reduction of methotrexate over 4 weeks.
Inclusion criteria
- Moderate to Severe Plaque Psoriasis